U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:USPH - US90337L1089 - Common Stock
71.63 USD
+3.22 (+4.71%)
71.63 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to USPH. USPH was compared to 100 industry peers in the Health Care Providers & Services industry. USPH has only an average score on both its financial health and profitability. USPH is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year USPH was profitable.
USPH had a positive operating cash flow in the past year.
USPH had positive earnings in each of the past 5 years.
USPH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of USPH (2.93%) is better than 64.00% of its industry peers.
USPH has a Return On Equity of 6.91%. This is in the better half of the industry: USPH outperforms 64.00% of its industry peers.
The Return On Invested Capital of USPH (5.72%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for USPH is below the industry average of 9.38%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.93% | ||
| ROE | 6.91% | ||
| ROIC | 5.72% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
1.3 Margins
USPH has a better Profit Margin (4.74%) than 77.00% of its industry peers.
In the last couple of years the Profit Margin of USPH has declined.
USPH has a Operating Margin of 11.00%. This is in the better half of the industry: USPH outperforms 79.00% of its industry peers.
In the last couple of years the Operating Margin of USPH has declined.
With a Gross Margin value of 18.96%, USPH is not doing good in the industry: 63.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of USPH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11% | ||
| PM (TTM) | 4.74% | ||
| GM | 18.96% |
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so USPH is destroying value.
USPH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, USPH has more shares outstanding
The debt/assets ratio for USPH has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.06 indicates that USPH is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.06, USPH is in line with its industry, outperforming 48.00% of the companies in the same industry.
The Debt to FCF ratio of USPH is 2.63, which is a good value as it means it would take USPH, 2.63 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 2.63, USPH is doing good in the industry, outperforming 77.00% of the companies in the same industry.
A Debt/Equity ratio of 0.30 indicates that USPH is not too dependend on debt financing.
USPH has a Debt to Equity ratio of 0.30. This is in the better half of the industry: USPH outperforms 66.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.63 | ||
| Altman-Z | 2.06 |
ROIC/WACC0.65
WACC8.79%
2.3 Liquidity
USPH has a Current Ratio of 1.18. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.18, USPH is in line with its industry, outperforming 42.00% of the companies in the same industry.
USPH has a Quick Ratio of 1.18. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
USPH has a Quick ratio (1.18) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
USPH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.17%.
The Earnings Per Share has been decreasing by -1.76% on average over the past years.
The Revenue has grown by 11.00% in the past year. This is quite good.
Measured over the past years, USPH shows a small growth in Revenue. The Revenue has been growing by 6.85% on average per year.
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
Revenue 1Y (TTM)11%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%
3.2 Future
The Earnings Per Share is expected to grow by 9.98% on average over the next years. This is quite good.
Based on estimates for the next years, USPH will show a quite strong growth in Revenue. The Revenue will grow by 9.97% on average per year.
EPS Next Y9.38%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
EPS Next 5YN/A
Revenue Next Year16.19%
Revenue Next 2Y11.04%
Revenue Next 3Y9.97%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
USPH is valuated quite expensively with a Price/Earnings ratio of 27.55.
USPH's Price/Earnings ratio is in line with the industry average.
USPH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.45, which is the current average of the S&P500 Index.
USPH is valuated rather expensively with a Price/Forward Earnings ratio of 22.96.
Compared to the rest of the industry, the Price/Forward Earnings ratio of USPH is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of USPH to the average of the S&P500 Index (34.46), we can say USPH is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.55 | ||
| Fwd PE | 22.96 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USPH indicates a somewhat cheap valuation: USPH is cheaper than 66.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, USPH is valued a bit cheaper than 69.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.89 | ||
| EV/EBITDA | 11.4 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates USPH does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.94
PEG (5Y)N/A
EPS Next 2Y9.96%
EPS Next 3Y9.98%
5. Dividend
5.1 Amount
USPH has a Yearly Dividend Yield of 2.53%.
Compared to an average industry Dividend Yield of 2.57, USPH pays a better dividend. On top of this USPH pays more dividend than 93.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, USPH has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.53% |
5.2 History
The dividend of USPH is nicely growing with an annual growth rate of 9.09%!
USPH has paid a dividend for at least 10 years, which is a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.09%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
USPH pays out 77.94% of its income as dividend. This is not a sustainable payout ratio.
The dividend of USPH is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP77.94%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
71.63
+3.22 (+4.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners105.82%
Inst Owner Change5.13%
Ins Owners1.84%
Ins Owner Change0.26%
Market Cap1.09B
Revenue(TTM)671.35M
Net Income(TTM)34.59M
Analysts84.62
Price Target108.32 (51.22%)
Short Float %5.28%
Short Ratio4.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.53% |
Yearly Dividend1.76
Dividend Growth(5Y)9.09%
DP77.94%
Div Incr Years4
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.25%
Min EPS beat(2)9.44%
Max EPS beat(2)11.07%
EPS beat(4)2
Avg EPS beat(4)2.96%
Min EPS beat(4)-7.64%
Max EPS beat(4)11.07%
EPS beat(8)3
Avg EPS beat(8)-1.31%
EPS beat(12)5
Avg EPS beat(12)-0.32%
EPS beat(16)8
Avg EPS beat(16)0%
Revenue beat(2)2
Avg Revenue beat(2)1.85%
Min Revenue beat(2)1.65%
Max Revenue beat(2)2.04%
Revenue beat(4)4
Avg Revenue beat(4)1.28%
Min Revenue beat(4)0.22%
Max Revenue beat(4)2.04%
Revenue beat(8)6
Avg Revenue beat(8)0.67%
Revenue beat(12)7
Avg Revenue beat(12)0.35%
Revenue beat(16)8
Avg Revenue beat(16)-0.06%
PT rev (1m)0%
PT rev (3m)0.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.75%
EPS NY rev (1m)0%
EPS NY rev (3m)8.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.55 | ||
| Fwd PE | 22.96 | ||
| P/S | 1.49 | ||
| P/FCF | 17.89 | ||
| P/OCF | 15.18 | ||
| P/B | 2.17 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.4 |
EPS(TTM)2.6
EY3.63%
EPS(NY)3.12
Fwd EY4.36%
FCF(TTM)4
FCFY5.59%
OCF(TTM)4.72
OCFY6.59%
SpS48
BVpS32.94
TBVpS-23.19
PEG (NY)2.94
PEG (5Y)N/A
Graham Number43.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.93% | ||
| ROE | 6.91% | ||
| ROCE | 7.57% | ||
| ROIC | 5.72% | ||
| ROICexc | 5.91% | ||
| ROICexgc | 34.97% | ||
| OM | 11% | ||
| PM (TTM) | 4.74% | ||
| GM | 18.96% | ||
| FCFM | 8.34% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
ROICexc(3y)6.35%
ROICexc(5y)7.3%
ROICexgc(3y)37.05%
ROICexgc(5y)44.29%
ROCE(3y)7.65%
ROCE(5y)8.96%
ROICexgc growth 3Y-11.04%
ROICexgc growth 5Y-7.52%
ROICexc growth 3Y-14.51%
ROICexc growth 5Y-13.29%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.63 | ||
| Debt/EBITDA | 1.49 | ||
| Cap/Depr | 49.29% | ||
| Cap/Sales | 1.49% | ||
| Interest Coverage | 9.81 | ||
| Cash Conversion | 70.13% | ||
| Profit Quality | 176.01% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 2.06 |
F-Score6
WACC8.79%
ROIC/WACC0.65
Cap/Depr(3y)54.79%
Cap/Depr(5y)61.53%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.57%
Profit Quality(3y)269.82%
Profit Quality(5y)263.85%
High Growth Momentum
Growth
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
EPS Next Y9.38%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
EPS Next 5YN/A
Revenue 1Y (TTM)11%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%
Revenue Next Year16.19%
Revenue Next 2Y11.04%
Revenue Next 3Y9.97%
Revenue Next 5YN/A
EBIT growth 1Y19.82%
EBIT growth 3Y-0.34%
EBIT growth 5Y0.76%
EBIT Next Year40.12%
EBIT Next 3Y18.72%
EBIT Next 5YN/A
FCF growth 1Y-1.2%
FCF growth 3Y-1.21%
FCF growth 5Y4.7%
OCF growth 1Y2.73%
OCF growth 3Y-0.65%
OCF growth 5Y3.71%
U.S. PHYSICAL THERAPY INC / USPH FAQ
What is the ChartMill fundamental rating of U.S. PHYSICAL THERAPY INC (USPH) stock?
ChartMill assigns a fundamental rating of 4 / 10 to USPH.
Can you provide the valuation status for U.S. PHYSICAL THERAPY INC?
ChartMill assigns a valuation rating of 3 / 10 to U.S. PHYSICAL THERAPY INC (USPH). This can be considered as Overvalued.
What is the profitability of USPH stock?
U.S. PHYSICAL THERAPY INC (USPH) has a profitability rating of 4 / 10.
Can you provide the expected EPS growth for USPH stock?
The Earnings per Share (EPS) of U.S. PHYSICAL THERAPY INC (USPH) is expected to grow by 9.38% in the next year.
Can you provide the dividend sustainability for USPH stock?
The dividend rating of U.S. PHYSICAL THERAPY INC (USPH) is 5 / 10 and the dividend payout ratio is 77.94%.